Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy
Authors
Keywords
-
Journal
JOURNAL OF PATHOLOGY
Volume 235, Issue 1, Pages 113-124
Publisher
Wiley
Online
2014-09-25
DOI
10.1002/path.4452
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Eliglustat tartrate
- (2014) J.A. Shayman DRUGS OF THE FUTURE
- Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy
- (2013) Mirella Belleri et al. BRAIN
- Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature
- (2013) Maarten Arends et al. BRITISH JOURNAL OF HAEMATOLOGY
- B cell lymphoma and myeloma in murine Gaucher's disease
- (2013) EV Pavlova et al. JOURNAL OF PATHOLOGY
- Use of a Glycolipid Inhibitor to Ameliorate Renal Cancer in a Mouse Model
- (2013) Subroto Chatterjee et al. PLoS One
- Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment
- (2012) Neal J. Weinreb et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Evaluation of miglustat as maintenance therapy after enzyme therapy in adults with stable type 1 Gaucher disease: a prospective, open-label non-inferiority study
- (2012) Timothy M Cox et al. Orphanet Journal of Rare Diseases
- Gaucher disease gene GBA functions in immune regulation
- (2012) J. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response
- (2011) N. Dekker et al. BLOOD
- Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study
- (2010) E. Lukina et al. BLOOD
- Safety, Tolerability, and Pharmacokinetics of Eliglustat Tartrate (Genz-112638) After Single Doses, Multiple Doses, and Food in Healthy Volunteers
- (2010) M. Judith Peterschmitt et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy
- (2010) John Marshall et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models
- (2010) Thomas A Natoli et al. NATURE MEDICINE
- Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage
- (2010) P. K. Mistry et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients
- (2009) Tamar H. Taddei et al. AMERICAN JOURNAL OF HEMATOLOGY
- Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature
- (2008) M. de Fost et al. ANNALS OF HEMATOLOGY
- Principles of bioactive lipid signalling: lessons from sphingolipids
- (2008) Yusuf A. Hannun et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More